THC Therapeutics, Inc. THCT
Set alert
0.00 USD 0.00 0.00%
At close · Oct 30
0.0001 Day range 0.0001
0.0001 52-week range 0.10
- YTD
- +600.00%
- 1 year
- +600.00%
- Open
- 0.0001
- Prev close
- 0.0007
- Mkt cap
- 27.21K
- Vol
- 227.61K
- Avg vol
- 265
- EPS
- -0.15
- P/E
- 0.00
More statistics
- Low
- 0.0001
- High
- 0.0001
3M chart
Signals (16)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 28, 2026 | 5 days ago |
| SMA: Bullish | Oct 28, 2026 | 5 days ago |
| RSI: Overbought | Oct 28, 2026 | 5 days ago |
| MACD: Buy Signal | Oct 19, 2026 | 2 weeks ago |
| MACD: Sell Signal | Sep 30, 2026 | 1 month ago |
| SMA: Bearish | Sep 29, 2026 | 1 month ago |
| SMA: Bearish | Sep 29, 2026 | 1 month ago |
| RSI: Oversold | Sep 29, 2026 | 1 month ago |
| RSI: Overbought | Sep 25, 2026 | 1 month ago |
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 15, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 4, 2026 | 1 month ago |
| SMA: Bearish | Sep 2, 2026 | 2 months ago |
| RSI: Oversold | Sep 2, 2026 | 2 months ago |
| SMA: Bullish | Aug 14, 2026 | 2 months ago |
Financial health
Altman Z-Score
-5100.61 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.0×
FY 2014 5y median -0.0× FY 2023
P/S 0.0×
FY 2014 5y median 0.0× FY 2023
P/B -0.0×
FY 2014 5y median -0.0× FY 2023
P/FCF -0.0×
FY 2014 5y median -0.0× FY 2023
EV/EBITDA -1.6×
FY 2014 5y median -0.5× FY 2023
EV/Sales 0.0×
FY 2014 5y median 0.0× FY 2023
FCF Yield -12152.4%
FY 2014 5y median -4093.2% FY 2023
Profitability
Gross Margin 0.0%
FY 2014 5y median 0.0% FY 2023
Operating Margin 0.0%
FY 2014 5y median 0.0% FY 2023
Net Margin 0.0%
FY 2014 5y median 0.0% FY 2023
ROE 11.7%
FY 2014 5y median 76.1% FY 2023
ROIC 20.4%
FY 2014 5y median 79.0% FY 2023
ROA -2979.5%
FY 2014 5y median -2255.7% FY 2023
Growth (YoY)
Revenue 0.0%
FY 2014 FY 2023
Operating Income 71.7%
FY 2014 FY 2023
EPS (diluted) 74.2%
FY 2014 FY 2023
Free Cash Flow 79.6%
FY 2014 FY 2023
Financial Health
Current Ratio 0.0×
FY 2014 5y median 0.0× FY 2023
Quick Ratio 0.0×
FY 2014 5y median 0.0× FY 2023
Debt / Equity -0.2×
FY 2014 5y median -0.2× FY 2023
Net Debt / EBITDA -1.6×
FY 2014 5y median -0.5× FY 2023
Interest Coverage -6.2×
FY 2014 5y median -6.2× FY 2023
Dividends
Dividend Yield 0.0%
FY 2014 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2014 5y median 0.0% FY 2023
Annual · latest fiscal year ends 2023-07-31
